| |
|
|
|
|
|
|
|||
|
U Gullberg, E Nilsson, MG Sarngadharan and I Olsson
A differentiation-inducing factor (DIF) for the promyelocytic HL-60 cell
line is constitutively produced by the malignant T lymphocyte line HUT-102.
DIF was highly purified from HUT-102-conditioned media by means of
diethylaminoethanol (DEAE)-chromatography, gel chromatography, and
high-resolution, ion-exchange chromatography on a MonoQ column and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). In addition
to inducing differentiation of wild-type HL-60 cells, resulting in
secondary inhibition of growth, DIF, at a tenfold lower concentration,
inhibited the growth of some clones of the monoblastic U- 937 cell line as
well as that of subclones of HL-60. The latter effect was most likely a
primary growth inhibition and not secondary to differentiation; 50%
inhibition of clonogenic growth in agar was seen at approximately 1.0
pmol/L of DIF. In addition, the clonogenic growth of fresh leukemia cells
from 10 of 12 patients with acute myeloid leukemia (AML) was inhibited with
50% inhibition at approximately 10 pmol/L of DIF. The growth of normal
granulocyte-macrophage colonies was inhibited at a similar concentration,
whereas early erythroid colonies were much more resistant. DIF and
interferon-gamma (gamma-IFN) were shown to be separate molecules inasmuch
as a neutralizing antibody for gamma-IFN did not abolish the DIF effect.
The differentiation effect on wild-type HL-60 and the proliferation
inhibitory effect on leukemic and normal myeloid cells cochromatographed
through all purification steps suggest that both activities are exhibited
by identical polypeptides. DIF may have a role in regulating normal
hemopoiesis. The growth inhibitory effect of DIF and the ability to induce
differentiation of some leukemia cells may suggest a clinical utility in
the treatment of leukemia.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1986 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||